Clinical trial design webinar

I'd like to invite readers interested in clinical trial design to sign up for our upcoming webinar on the topic. Tufts' Kenneth Kaitin and Neil Patel from PricewaterhouseCoopers will be on hand to discuss some of the latest trends in the field. We've already received some tremendous response for this webinar, with about 500 registered attendees. Don't miss it.

Also, as usual we're taking off July 4th, so we won't be back until Monday. For our readers in the U.S., enjoy the long weekend. For everyone else, we'll be back Monday. - John Carroll

Suggested Articles

Janssen’s BCMA-targeting CAR-T therapy eliminated tumors in 69% of patients with advanced multiple myeloma in a small phase 1 study.

In a study, BMS' CAR-T therapy banished tumors in more than half and shrank tumors in nearly three-quarters of relapsed blood cancer patients.

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.